ANNA BOSSERT D.O.
Prescription History 1386094621
Obstetrics & Gynecology in West Reading, PA

Active since June 17, 2016PECOS EnrolledAccepts Medicare Assignment
81.19/100
CMS Quality Rating
420 S 5TH AVE, WEST READING, PA 19611(484) 628-8838(484) 345-2393 Get Directions

NPPES record last updated: June 17, 2016. Verified against the NPPES registry weekly; last sync: August 09, 2026.

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ANNA BOSSERT D.O., an active Obstetrics & Gynecology specialist practicing in West Reading, PA. Our medical registry currently tracks 3 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 63 documented patient claims. Among these therapy options, the most frequently utilized medication is Estradiol, which accounts for 38 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

3
Medications
63
Total Claims
159
30-Day Fills
Estradiol
Most Prescribed · 38 claims
View details
3 medications · 2023 Medicare Part D
Medicare Part D medications prescribed by ANNA BOSSERT D.O. in 2023, with prescription volumes, average cost per fill, and PA state comparisons
Medication Prescriptions (2023)Rx (2023) Avg Cost per FillCost / Fill Vs. Other PA PrescribersVs. PA Avg
Estradiol38$122.26 Typical

About Estradiol: This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 38 Medicare prescriptions for Estradiol, about 1.2 times the volume of the typical Pennsylvania prescriber of this medication (32). Medicare paid an average of $122.26 per fill, versus $104.30 statewide.

How often this provider prescribes it

This provider
38
PA average
32.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$122.26
PA average
$104.30

Gross Part D cost per fill; not the patient's out-of-pocket price.

88.2
30-Day Fills
standardized to 30-day supplies
2,583
Days of Medication
total across all patients in 2023
Estradiol (Twice Weekly)Estradiol14$127.05 Typical

About Estradiol (Twice Weekly): This medication is a female hormone (estrogen). Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.

In 2023, this provider wrote 14 Medicare prescriptions for Estradiol (Twice Weekly), about 78% of the volume of the typical Pennsylvania prescriber of this medication (18). Medicare paid an average of $127.05 per fill, versus $107.53 statewide.

How often this provider prescribes it

This provider
14
PA average
18.0

This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$127.05
PA average
$107.53

Gross Part D cost per fill; not the patient's out-of-pocket price.

39.2
30-Day Fills
standardized to 30-day supplies
1,176
Days of Medication
total across all patients in 2023
PremarinEstrogens, Conjugated11$443.15 Less than typical

About Premarin: This medication is a female hormone. Show more ▾

It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.

In 2023, this provider wrote 11 Medicare prescriptions for Premarin, about half the volume of the typical Pennsylvania prescriber of this medication (21). Medicare paid an average of $443.15 per fill, versus $402.19 statewide.

How often this provider prescribes it

This provider
11
PA average
21.0

This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$443.15
PA average
$402.19

Gross Part D cost per fill; not the patient's out-of-pocket price.

31.9
30-Day Fills
standardized to 30-day supplies
956
Days of Medication
total across all patients in 2023
No medications match the current filters.
More than typical Typical Less than typical= prescription volume vs the average PA prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the PA average cost per fill.

About this data. The prescription history for ANNA BOSSERT D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Obstetrics & Gynecology prescribing approach at this West Reading, PA practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among PA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.